Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,656 Cr₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr

What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of TORRENT PHARMACEUTICALS is ₹1,656 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,656 Cr
Mar2024₹1,245 Cr
Mar2023₹777 Cr
Mar2022₹1,252 Cr
Mar2021₹1,025 Cr

How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,656 Cr
33.02
Mar2024 ₹1,245 Cr
60.22
Mar2023 ₹777 Cr
-37.92
Mar2022 ₹1,252 Cr
22.17
Mar2021 ₹1,025 Cr -

Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹141,840.4 Cr 1.8% -1.8% 30.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics
MANKIND PHARMA ₹92,744.0 Cr -0.9% 10.1% -11.6% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

1.8%

-1.8%

30.7%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses